Cape Biologix Technologies
The Business Development Executive will leverage sales cycle expertise and technical knowledge of recombinant proteins to drive growth of diagnostic proteins for rapid test kit manufacturers across Africa and LMICs. The role focuses on acquiring new customers, retaining and expanding existing accounts, and providing market feedback to shape the company’s growth strategy.
Cape Biologix Technologies, a subsidiary of Cape Bio Pharms, is a biotechnology company that manufactures plant-made recombinant proteins for research and diagnostic applications. Using their proprietary transient plant-based expression platform (PtX™), they turn Nicotiana benthamiana plants into mini-bioreactors to produce high-quality antibodies and antigens without the use of animals. Founded in 2020 and based in Cape Town, South Africa, the company aims to contribute to global biosecurity by providing accessible, economical, and ethically sourced biological proteins.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cape Biologix Technologies.
Cape Biologix Technologies didn’t post a salary, so this is our estimate from similar listings.
22% below the average for this role